Advancing Cancer Drug Resistance Research: Exclusive APC Discount Campaign for National Cancer Survivors Month 2025
In honor of National Cancer Survivors Month 2025, Cancer Drug Resistance (CDR) is offering a limited-time APC discount to support researchers in the vital field of cancer drug resistance. This initiative aims to promote global collaboration and raise awareness about the ongoing challenges faced by cancer survivors and the importance of overcoming drug resistance in cancer treatment.
❓ Why This Initiative?
National Cancer Survivors Day (June 1st) is a time to celebrate individuals who have overcome cancer and to reflect on the importance of advancing cancer research. Through this APC discount initiative, we aim to reduce financial barriers for researchers, accelerate the dissemination of critical findings, and contribute to the global fight against cancer
📅 Discount Period: May 15 – June 30, 2025
👥 Who Is Eligible?
Researchers worldwide are invited to participate, with special encouragement for submissions from Europe and North America. Discounts are available for all submissions between May 15 – June 30, 2025.
💡 Two Ways to Save on APCs
| Submission Option | Requirements | APC Discount |
|---|---|---|
| 🧪 Full Manuscript Submission | Submit the full paper by June 30, 2025 | 40% OFF (Reduced from USD 2800 to USD 1680) |
| 📝 Early Registration (Intent to Submit) | Send title, abstract, authors info, and expected submission date to the Editorial Office ([email protected]) by June 30, 2025 | 20% OFF (Reduced from USD 2800 to USD 2240) |
📧 Email to: [email protected]
🔔 Note: If your manuscript qualifies for both discounts, the higher discount will be automatically applied. Discounts are applied only after peer review and acceptance.
✨ Additional Author Benefits
1. Priority Peer Review
• All eligible submissions will receive accelerated peer review, with an initial decision targeted within 4–6 weeks.
2. Enhanced Visibility & Promotion
• Published papers will be featured on the journal’s website, in email newsletters, and across social media for broader exposure.
• Selected high-impact articles will receive additional promotion through special features in journal newsletters.
3. Exclusive Author Interviews & Webinars
• Selected authors will be invited for online academic interviews or panel discussions, sharing their research journeys and groundbreaking discoveries.
• Featured researchers may also be invited to speak at CDR-hosted webinars, further expanding their academic influence.
📚 Eligible Submission Types
All submission types are welcome, including:
• Original Research
• Review Articles
• Commentaries
• Perspectives
• Opinions
🔹 Note: APC discounts will be applied only after successful peer review and accepance for publication.
June marks Cancer Survivors Month—a time to honor the strength, courage, and resilience of millions who have faced cancer. It is also a moment to reflect on the progress made in cancer research and to reaffirm our commitment to breakthroughs that improve outcomes and quality of life for survivors worldwide.
We invite researchers across all oncology and related disciplines to contribute to this special initiative. Your work is vital to transforming survivorship from a possibility into a reality. Whether your research focuses on prevention, treatment, survivorship care, or basic science, it contributes to the global pursuit of hope and healing.
Let us use this occasion to highlight the power of scientific discovery in the fight against cancer. Together, we can illuminate new paths forward, celebrate lives saved, and recommit ourselves to the mission of a future free from cancer.
Submit your research and join this collective journey of resilience, progress, and hope.
For any inquiries, please contact the Editorial Office at [email protected].
Editor: Louise Pan
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Cancer Drug Resistance
